Focus Partners Advisor Solutions LLC Lowers Stock Holdings in Cigna Group $CI

Focus Partners Advisor Solutions LLC lowered its stake in Cigna Group (NYSE:CI) by 52.7% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,764 shares of the health services provider’s stock after selling 4,192 shares during the period. Focus Partners Advisor Solutions LLC’s holdings in Cigna Group were worth $1,038,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in CI. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group in the 4th quarter worth about $25,000. Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new position in Cigna Group in the fourth quarter worth about $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the fourth quarter worth about $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in shares of Cigna Group in the second quarter worth approximately $34,000. 86.99% of the stock is owned by institutional investors.

Cigna Group Stock Down 0.1%

CI stock opened at $282.24 on Monday. The company has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.29. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. The business’s 50-day moving average is $286.02 and its two-hundred day moving average is $281.28. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the company posted $7.20 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Insider Buying and Selling

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CI shares. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a research report on Monday, August 3rd. Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Finally, Morgan Stanley lifted their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.